Shockwave Medical, Inc.
SWAV
$330.55
$0.5450.17%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -31.81% | 177.06% | 343.68% | 730.06% | 2,464.23% |
| Total Depreciation and Amortization | 113.30% | 109.43% | 74.91% | 64.74% | 35.68% |
| Total Amortization of Deferred Charges | 182.74% | -0.80% | -39.63% | -16.90% | 4.31% |
| Total Other Non-Cash Items | 276.65% | -145.78% | -181.92% | -212.66% | -224.92% |
| Change in Net Operating Assets | 24.29% | 1.97% | -29.92% | -61.95% | -250.71% |
| Cash from Operations | 66.52% | 105.26% | 163.48% | 336.92% | 683.00% |
| Capital Expenditure | -21.77% | -98.93% | -171.87% | -148.66% | -101.99% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,252.42% | -778.26% | 128.30% | 102.89% | -195.29% |
| Cash from Investing | -906.80% | -737.88% | -138.75% | -1.67% | -335.27% |
| Total Debt Issued | 3,253.28% | -- | -- | -- | -- |
| Total Debt Repaid | -477.05% | -4,279.85% | -- | -- | -- |
| Issuance of Common Stock | 7.87% | 24.67% | 32.56% | 22.11% | 19.76% |
| Repurchase of Common Stock | -86.96% | -866.67% | -300.00% | 99.38% | 99.72% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4,518.82% | 15,533.13% | -141.53% | 2,772.07% | 630.35% |
| Foreign Exchange rate Adjustments | 169.12% | 147.15% | 155.24% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 154.38% | 890.66% | 157.72% | 2,169.63% | 72.89% |
